Saved in:
| Format: | Artículo Open Access |
|---|---|
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/pcn.70013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
by: Yasmin Esmaeilian, et al.
Published: (2026)
by: Yasmin Esmaeilian, et al.
Published: (2026)
Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder
by: Shugui Gao, et al.
Published: (2025)
by: Shugui Gao, et al.
Published: (2025)
Acute and long‐term effects of repeated ketamine infusions in treatment‐resistant depression and associated metabolite changes
by: Hitoshi Sakurai, et al.
Published: (2025)
by: Hitoshi Sakurai, et al.
Published: (2025)
Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
by: Beatrice Bravi, et al.
Published: (2024)
by: Beatrice Bravi, et al.
Published: (2024)
Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
by: Alexander A. Yakovlev
Published: (2024)
by: Alexander A. Yakovlev
Published: (2024)
Habenular volume changes after venlafaxine treatment in patients with major depression
by: Josselin Etienne, et al.
Published: (2024)
by: Josselin Etienne, et al.
Published: (2024)
Effects of routine repetitive transcranial magnetic stimulation on the sleep duration of patients with treatment‐resistant depression: A prospective cohort study
by: Khosro Sadeghniiat, et al.
Published: (2024)
by: Khosro Sadeghniiat, et al.
Published: (2024)
Accelerated intermittent theta burst stimulation for pharmacological treatment‐resistant bipolar depression: Protocol for double‐blind, randomized, sham‐controlled trial
by: Taro Kishi, et al.
Published: (2025)
by: Taro Kishi, et al.
Published: (2025)
Functional and structural connectivity of thalamic subnuclei in major depressive disorder at 7 Tesla
by: Weijian Liu, et al.
Published: (2026)
by: Weijian Liu, et al.
Published: (2026)
Advancing posttraumatic stress disorder treatment: A novel approach in treatment‐resistant childhood sexual abuse posttraumatic stress disorder
by: Toshiaki Onitsuka
Published: (2024)
by: Toshiaki Onitsuka
Published: (2024)
The longitudinal patterns of depression subtypes and stressors in depression severity in the Canadian longitudinal study on aging (CLSA)
by: Yingying Su, et al.
Published: (2024)
by: Yingying Su, et al.
Published: (2024)
Early identification of postpartum depression using machine learning
by: Yukako Nakamura, et al.
Published: (2024)
by: Yukako Nakamura, et al.
Published: (2024)
Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
by: Toru Horinouchi, et al.
Published: (2026)
by: Toru Horinouchi, et al.
Published: (2026)
Plasma circulating microRNAs and symptoms of depression: Results from a population‐based study
by: Midas M. Kuilman, et al.
Published: (2025)
by: Midas M. Kuilman, et al.
Published: (2025)
Comparison of multiple non‐invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta‐analysis of randomized controlled trials
by: Ping Wang, et al.
Published: (2025)
by: Ping Wang, et al.
Published: (2025)
Comparison of depression with anxious distress and melancholic depression from the perspective of psychomotor disturbance
by: Yu Tamada, et al.
Published: (2024)
by: Yu Tamada, et al.
Published: (2024)
Effects of particulate matter exposures on depressive symptom trajectories: Evidence from a national longitudinal survey in China
by: Hengchang Wang, et al.
Published: (2026)
by: Hengchang Wang, et al.
Published: (2026)
Association of objective body shape and perceived body image with depressive symptoms in men and women
by: Seong‐Uk Baek, et al.
Published: (2025)
by: Seong‐Uk Baek, et al.
Published: (2025)
Dynamic cognitive differences between internal and external attention are associated with depressive and anxiety symptoms
by: Taiki Oka, et al.
Published: (2025)
by: Taiki Oka, et al.
Published: (2025)
Glymphatic dysfunction as an indicator of disease burden and a potential biomarker in anti‐ NMDAR encephalitis
by: Han Cai, et al.
Published: (2025)
by: Han Cai, et al.
Published: (2025)
Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
by: Chieh‐Hsin Lin, et al.
Published: (2025)
by: Chieh‐Hsin Lin, et al.
Published: (2025)
Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population
by: Tomoyuki Ohara, et al.
Published: (2024)
by: Tomoyuki Ohara, et al.
Published: (2024)
Effects of childhood experiences of parental attitude, depressive rumination, and sleep disturbances on adulthood depressive symptoms
by: Shinichi Akiyama, et al.
Published: (2024)
by: Shinichi Akiyama, et al.
Published: (2024)
Altered cardiac timing neural avalanche in major depressive disorder: new insights from magnetoencephalography
by: Qian Liao, et al.
Published: (2025)
by: Qian Liao, et al.
Published: (2025)
From relay station to circuit hub: Thalamic subnuclear precision and the major depressive disorder dysfunctome
by: Yuehua Zhao, et al.
Published: (2026)
by: Yuehua Zhao, et al.
Published: (2026)
Response to ‘Potential role of anti‐inflammatory cytokines in postpartum depression: Considerations for future research and improvement’
by: Chiaki T. Ono, et al.
Published: (2024)
by: Chiaki T. Ono, et al.
Published: (2024)
Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
by: Junneng Shao, et al.
Published: (2026)
by: Junneng Shao, et al.
Published: (2026)
The effects of potentially traumatic events on the recovery from pre‐existing anxiety and depression symptomatology and the risk of PTSD
by: Peter G. van der Velden, et al.
Published: (2024)
by: Peter G. van der Velden, et al.
Published: (2024)
Surgical treatment may improve depressive and hysterical traits in temporal lobe epilepsy with hippocampal sclerosis: Study using the Minnesota Multiphasic Personality Inventory
by: Hiroyuki Otabe, et al.
Published: (2024)
by: Hiroyuki Otabe, et al.
Published: (2024)
Improvement in avoidance in major depressive disorder: A 10‐month prospective study of depressive symptoms and personality traits
by: Ryotaro Higuchi, et al.
Published: (2026)
by: Ryotaro Higuchi, et al.
Published: (2026)
Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention
by: Hiroe Hu, et al.
Published: (2024)
by: Hiroe Hu, et al.
Published: (2024)
Association between the Japanese‐style diet and low prevalence of depressive symptoms: Japan Epidemiology Collaboration on Occupational Health Study
by: Haruka Miyake, et al.
Published: (2025)
by: Haruka Miyake, et al.
Published: (2025)
The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
by: Sara Medved, et al.
Published: (2024)
by: Sara Medved, et al.
Published: (2024)
Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: A nationwide longitudinal study in Taiwan
by: Mao‐Hsuan Huang, et al.
Published: (2024)
by: Mao‐Hsuan Huang, et al.
Published: (2024)
White matter alterations in the corpus callosum and visual cortical regions associated with depressive and psychotic symptoms in early‐onset bipolar disorder
by: Zheng Bi, et al.
Published: (2026)
by: Zheng Bi, et al.
Published: (2026)
REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disorders
by: Marc Ferrer, et al.
Published: (2025)
by: Marc Ferrer, et al.
Published: (2025)
Acute prefrontal hemodynamic responses to intermittent theta burst stimulation correlate with current depression and episode recurrence: A cross‐sectional study
by: Minxia Jin, et al.
Published: (2026)
by: Minxia Jin, et al.
Published: (2026)
Unraveling the gut‐brain connection: The association of microbiota‐linked structural brain biomarkers with behavior and mental health
by: Oren Contreras‐Rodriguez, et al.
Published: (2024)
by: Oren Contreras‐Rodriguez, et al.
Published: (2024)
Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder
by: Aleena Francis, et al.
Published: (2026)
by: Aleena Francis, et al.
Published: (2026)
Examining the feasibility and limitations of AST‐001 as a treatment for autism spectrum disorder
by: Chenxi Wang, et al.
Published: (2024)
by: Chenxi Wang, et al.
Published: (2024)
Similar Items
-
Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
by: Yasmin Esmaeilian, et al.
Published: (2026) -
Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder
by: Shugui Gao, et al.
Published: (2025) -
Acute and long‐term effects of repeated ketamine infusions in treatment‐resistant depression and associated metabolite changes
by: Hitoshi Sakurai, et al.
Published: (2025) -
Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
by: Beatrice Bravi, et al.
Published: (2024) -
Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
by: Alexander A. Yakovlev
Published: (2024)